{
  "id": "OPM-2025-0004-14435",
  "title": "Comment from Anonymous",
  "category": "Citizen",
  "analysis": {
    "stance": "Against",
    "themes": [
      "Merit-based system concerns",
      "Due process/employee rights",
      "Politicization concerns",
      "Institutional knowledge loss"
    ],
    "key_quote": "Schedule Policy/Career poses a substantial threat to the effectiveness of the drug review process that has been established and fine-tuned over decades and to the integrity and quality of drug products.",
    "rationale": "The comment expresses strong opposition to the proposed rule, highlighting concerns about the loss of merit-based employment principles, due process rights, and the potential for politicization within the civil service. The emphasis on protecting impartial science and the integrity of the drug review process further underscores the opposition to the rule."
  },
  "occurrence_number": 0,
  "duplicate_of": ""
}